A top-10 global pharmaceutical company had multiple drugs in their Immunology Business Unit indicated for both acute and prophylactic treatments, including the market-leading therapy with $1B+ in annual revenue. They needed to better understand the impact of new entrants across the complete product portfolio.
Viscadia was asked to design, build and deploy forecasting platforms that addressed the end-to-end forecasting needs of the full portfolio, including short-term evaluations, long-range planning, market forecasting and patient analytics.
Constructed comprehensive patient flow model, capturing complex fulfillment dynamic with intuitive UI design
Created cannibalization matrix to track movement of patients across different products and segments in market with new product launches
Managed client’s complete portfolio through dynamic, individual forecasting models that cater to different cross-functional needs
Evaluated near-term future of the overall market, drawing on inputs from KOLs, practitioners and payers, and their positioning/ projected uptake for the product opportunity
Built capability to streamline data extraction and processing from multiple sources to ensure consistency. Informed key forecast drivers such as persistency, titration curves, and compliance —with ability to update them in real-time
Performed deep dives into patient-level data to generate valuable new business KPIs